Table of Contents
Evoq Remedies Limited IPO Details, Financials, Subscription Status, GMP & More.
You can even check more Evoq Remedies Limited IPO’s latest news from this portal. Our mission is to keep you up to date on Upcoming IPO information.
Evoq Remedies IPO Details
IPO Opening Date | Mar 17, 2022 |
IPO Closing Date | Mar 22, 2022 |
Type Of Issue | Fixed Price Issue IPO |
Current Face Value | ₹10 per equity share |
IPO Price | ₹27 per equity share |
Market Lot Size | 4000 Shares |
Minimum Order Quantity | 4000 Shares |
Will Be Listed At | BSE SME |
Issue Size | 3,600,000 Eq Shares of ₹10 (aggregating up to ₹9.72 Cr) |
Fresh Issue | 3,600,000 Eq Shares of ₹10 (aggregating up to ₹9.72 Cr) |
Retail Shares Offered | 50% |
NII (HNI) Shares Offered | 50% |
Evoq Remedies Limited IPO Prospectus
This table shows all information about Evoq Remedies Limited IPO. You can check more detailed information like company registrar information of this IPO and more information about the company address from this page itself.
Company Financial Reports
Year/Period (Rs in Lakhs) | |||||
---|---|---|---|---|---|
10-Feb-22 | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | ||
Total Assets | 2660.58 | 804.63 | 565.22 | 214.78 | |
Total Revenue | 1056.58 | 1002.48 | 907.21 | 325 | |
Profit After Tax | 93.67 | 71.38 | 0.03 | 1.11 |
With the help of the above information, you can figure out company performance over the last few years. You can identify if the company is making profits or losses.
Evoq Remedies IPO Timetable
The Evoq Remedies IPO open date is Mar 17, 2022, and the close date is Mar 22, 2022. The issue may list on Mar 30, 2022.
IPO Open Date | Mar 17, 2022 |
IPO Close Date | Mar 22, 2022 |
Basis of Allotment Date | Mar 25, 2022 |
Initiation of Refunds | Mar 28, 2022 |
The credit of Shares to Demat Account | Mar 29, 2022 |
IPO Listing Date | Mar 30, 2022 |
This table is helpful as it provides you the complete information about the upcoming IPO’s lot size, several shares, and the minimum amount required to apply for this IPO.
Evoq Remedies IPO Lot Size
The Evoq Remedies IPO market lot size is 4000 shares. A retail-individual investor can apply for up to 1 lot (4000 shares or ₹108,000).
Application | Lots | Shares | Amount (Cut-off) |
---|---|---|---|
Minimum | 1 | 4000 | ₹108,000 |
Maximum | 1 | 4000 | ₹108,000 |
Company Promoters & Holding
Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the company promoters.
Company Promoters play a vital role in any company’s success. That’s you need a clear idea about who are the promoters behind this company. You can even check the names given below for a better idea.
Company Registrar & Address
Evoq Remedies IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: [email protected]
Website: http://www.bigshareonline.com
You can also check the company contact information given below, with the help of this information you can communicate with the company easily.
Company Contact Information
Evoq Remedies Limited
A-1106, Empire Business Hub
Near AUDA Water Tank,
Science City Road, Sola, Ahmedabad-380060
Phone: 7948402525
Email: [email protected]
Website: http://www.evoqremedies.com/
This is the complete information about the Evoq Remedies Limited IPO. If you have any queries/questions regarding any information provided above then feel free to contact us anytime or leave a comment below.
Evoq Remedies Limited IPO Subscription Status
Day 1 (times) | Day 2 (times) | Day 3 (times) | Day 4 (times) | |
QIB | 0.00 | 0.00 | 0.00 | 0.00 |
NII | 0.00 | 0.00 | 0.00 | 0.00 |
Retail | 0.00 | 0.00 | 0.00 | 0.00 |
Total | 0.00 | 0.00 | 0.00 | 0.00 |
Evoq Remedies Limited IPO Subscription Status will be updated in the table regularly. Keep visiting this page to get daily latest IPO subscription updates. If this table is not updated then you can request the updates by commenting below. (Updated Frequently)
GMP (Grey Market Premium)
We are here to provide you with detailed information about the current GMP OF IPO from this page itself. Just be with us and request updates about the IPO Grey Market Premium.